2020
DOI: 10.4103/meajo.meajo_130_19
|View full text |Cite
|
Sign up to set email alerts
|

Corneal Cross-linking as an Adjunct for The Management of Refractory Fungal Keratitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…PACK-CXL in conjunction with topical therapy has shown success in bacterial keratitis but less so in fungal keratitis [83][84][85]. Although some studies have shown it equivalent to intrastromal voriconazole [86], others have shown an increased risk of perforations and an increased need for therapeutic keratoplasty [87]. Future larger studies are required to determine a more consistent answer.…”
Section: Collagen Cross-linkingmentioning
confidence: 99%
“…PACK-CXL in conjunction with topical therapy has shown success in bacterial keratitis but less so in fungal keratitis [83][84][85]. Although some studies have shown it equivalent to intrastromal voriconazole [86], others have shown an increased risk of perforations and an increased need for therapeutic keratoplasty [87]. Future larger studies are required to determine a more consistent answer.…”
Section: Collagen Cross-linkingmentioning
confidence: 99%
“…Fungal keratitis is painful and may require hospitalization for intensive medical treatment and/or surgical interventions. Treatment of fungal keratitis with systemic and topical antifungal agents has been only partially successful due to the high resistance to antifungal agents ( 2 ). Natamycin and voriconazole are not sufficient for treating non-responsive fungal keratitis due to their limited efficacy ( 3 ).…”
Section: Introductionmentioning
confidence: 99%
“…There appears to be no benefit of adjuvant CXL in the primary treatment of moderate filamentous fungal ulcers and it may result in decreased visual acuity Mikropoulos et al 2019 130 (Case report) Intraoperative PACKCXL during PKP for the management of fungal keratitis in an immunocompromised patient 1 Purpureocillium lilacinum 9 mW/cm 2 for 10 minutes (total 5.4 J/cm 2 ) No signs of infection were noted, and the graft remained clear during the 9-month follow-up period Wei et al 2019 131 (Randomized controlled study) Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis 21 Aspergillus in 8 eyes, Fusarium in 5, and unidentified in 7 cases (1 missing) 3 mW/cm 2 for 30 minutes (total 5.4 J/cm 2 ) CXL accelerated healing, shortened the treatment duration, and minimized the need for medications and surgery. CXL is an effective procedure and adjuvant therapy for managing fungal keratitis Bamdad et al 2020 132 (Prospective interventional) Corneal Cross-linking as an Adjunct for The Management of Refractory Fungal Keratitis 9 Aspergillus in 4 eyes, Fusarium in 4, and candida in 1 3 mW/cm 2 for 30 minutes (total 5.4 J/cm 2 ) Four out of 9 eyes showed good response and infection was completely halted and scared down. Five out of 9 patients showed no response, and therapeutic PKP was performed to preserve the globe.…”
Section: Introductionmentioning
confidence: 99%